Professional Documents
Culture Documents
VENTURE CAPITAL
2015 REPORT
Contents
Introduction 2
Fund Details 12
Investee Companies 17
Fund Details 28
Investee Companies 31
Seed and Venture Capital Measure of the Operational Programme 1994 1999 34
This 2015 SVC Report comprises four venture Enterprise Ireland commitment of 43 million
capital initiatives undertaken by Enterprise a number of other funds will be announced
Ireland in partnership with the private sector. shortly. Under the second call, a further
65m was committed to a number of venture
Seed and Venture Capital Programme capital funds targeting early stage funding.
2013 2018 These funds are now at the final stages of
Seed and Venture Capital Programme fund raising and it is expected that a number
2007 2012. of funds will be launched in the near term. A
further allocation has also been made to a
Seed and Venture Capital Programme
new European Angel Fund.
2000 2006, under the National
Development Plan. Under the 20072012 Programme, Enterprise
Ireland committed 175 million to continue to
The EU Seed and Venture Capital
develop the seed and venture capital market
Measure 1994 1999, under the
in Ireland. Up to December 2015 thirteen
Operational Programme for Industrial
new funds were launched with an Enterprise
Development.
Ireland commitment of 174 million.
All funds are independently managed by Under the 20002006 Programme,
private sector fund managers who make all Enterprise Ireland committed 98 million to
decisions regarding investments. develop the venture capital market for SMEs
In May 2013, the 175 million Seed and in Ireland. This Programme committed to
Venture Capital Programme (2013-2018) was fifteen funds.
launched. The objective of this Programme The EU Seed and Venture Capital Measure
is to support the development of high- under the Operational Programme for
growth Irish companies with the potential Industrial Development 19941999 was set
to grow jobs and generate large amounts up with the objective of establishing Venture
of additional exports. As of December 2015, Capital Funds to provide early stage small
the 175m has been fully allocated in 2 and medium-sized enterprises in Ireland
separate competitive calls in 2013 and 2015. with equity capital. Fifteen separate venture
99.5m was committed as part of the first capital initiatives were established with 68
call targeting Series A funding. Three new million committed under this Programme, the
Funds have now been established with an first of which was launched in May 1996.
Notes:
1. For reporting purposes, each tranche of money paid to a company is counted as an investment.
2. Some investee companies have secured funding from more than one Fund.
3. Regional breakdown of data for the Seed and Venture Capital Programme is in accordance with EU regional guidelines.
4. Investments continue to be classed in this report as per the development status when the first investment was made in the company.
5. Start up investments includes seed investments.
6. Stage of Development interpretation in Seed Funds can differ from that of other Venture Capital Funds.
7. Disclaimer
Enterprise Ireland has endeavoured to ensure the reliability of the data included in this Report and does not assume any responsibility for
any inaccuracy in the data. In addition Enterprise Ireland does not assume any responsibility as regards the use of the data contained in this
Report by any third parties. The collective data as presented in this Report has not been subjected to independent audit.
At the heart of Enterprise Irelands strategy, build on the success of the previous seed funds
Driving Enterprise | Delivering Jobs, is the and targeted funds who were seeking to invest
intention to establish Irish enterprise as a in early-stage ventures. Our Board committed
powerful engine of job creation and growth in a total of 65m to seven commercially focused
towns and villages right across the country. early-stage funds. These funds are actively
2015 was an excellent year for Irish enterprise. fundraising and it is expected that a number of
funds will be launched in the near term.
Access to appropriate and adequate capital,
to fund international growth strategies, is On an ongoing basis, Enterprise Ireland works
a precursor to business success and so the with key players within the business ecosystem,
impressive achievements of Irish companies to optimise the funding options for SMEs. For
during 2015 is attributable also, to the Irish example, Enterprise Irelands 75m commitment
venture capital sector. under the Development Capital Scheme, three
funds have been created with a combined total
In 2015, venture capital funds supported under
fund size of 492m. In 2015 these funds were
the Enterprise Ireland Seed and Venture Capital
very active in the market and invested a total of
Scheme made 144 investments in Irish based
74m into companies in the food, logistics and
companies, with a total investment value of
internationally traded services sectors in Ireland.
54 million.
Business Angels are an important element of
Start-up companies are the lifeblood of any
the business ecosystem, contributing both
developed economy and a key focus for
expertise and investment capital. Enterprise
Enterprise Ireland, as they account for over
Ireland, in partnership with InterTrade Ireland
two thirds of all new jobs. During 2015, over
continued to support the Halo Business Angel
200 early stage companies were approved for
Network, which resulted in over 10.8m of
investment by Enterprise Ireland, with Enterprise
business angel investment in 50 companies in
Ireland directly investing 31m into 105 High
2015. In addition we are continuing to work with
Potential Start-Up businesses. These businesses
the European Investment Fund to launch a new
will create an estimated 1,500 jobs over the next
20m European angel fund that will increase the
three years.
availability of capital for this market and further
In 2015, we completed the commitment of develop the angel ecosystem.
the 175m available under the current Seed &
In 2016, the global outlook remains positive
Venture Capital Scheme (2013-2018). Under this
but winning market share for our exports is
scheme, three new funds have been successfully
always challenging. We will continue to work
launched which will make a further 289m
in close partnership with the Seed and Venture
of venture funding available in the market.
Capital sector to ensure that Irish businesses
Fountain Healthcare Partners II, The Bank of
can access adequate capital to achieve their full
Ireland Kernel Capital Growth Fund (ROI) II and
international growth potential.
Atlantic Bridge III are all active and seeking
investment opportunities.
* 17.8 million of the Bank of Ireland Kernel Capital ROI Growth Funds relates to the Seed and Venture Capital Programme
2007-2012.
Atlantic Bridge III L.P. is a Fountain Healthcare Partners These funds are actively
growth equity fund focused Fund II is a Life Science investing in the Republic of
on technology investments focused venture capital fund Ireland in the 1,000,000 to
with offices and staff in Dublin, that invests in the 3,000,000 3,000,000 range. A separate
London, Silicon Valley, Beijing to 10,000,000 range in parallel Kernel Capital Fund
and Hong Kong. Atlantic biotechnology, specialty operates in Northern Ireland.
Bridge III has been actively pharma, medical devices
Kernel Capital with a team of
investing since January 2015. and diagnostic companies.
twelve executives have offices
The fund is open for new The fund is open for new
in Cork, Belfast and Dublin.
investments. investments.
FUND SIZE: 138 million FUND SIZE: 103 million FUND SIZE: 47 million
TEL: +353 (0)1 6034450 TEL: +353 (0)1 5225100 TEL: +353 (0)21 4928974
SEED FUNDS
AIB Seed Capital Fund Limited 53,000 22 2,175 180 32,342
Partnership
SEED FUNDS
Start Up 105 22,293 28.81%
Development 0 0 0.00%
SEED FUNDS
Breakdown of
Investments
Cumulative to
December 2015
(% by value)
28.81% Start Up
VENTURE
CAPITAL FUNDS
Breakdown of
Investments 32.10% Development
Cumulative to
December 2015 26.32% Start Up
(% by value)
41.58% Early Stage
REGIONAL
BREAKDOWN OF
INVESTMENTS
Cumulative to
December 2015
(% by value)
0.15% Border
26.34% Other
12.87% West
SECTORAL
BREAKDOWN OF 11 Miscellaneous
INVESTMENTS
2 Electronics
Cumulative to
December 2015 104 Communications
(by number)
33 Cleantech
477 Software
5 Manufacturing
1 Food
SECTORAL
BREAKDOWN OF 2.60% Miscellaneous
INVESTMENTS
0.11% Electronics
Cumulative to
December 2015 2.82% Cleantech
(% by value)
9.38% Communications
48.90% Software
0.82% Manufacturing
0.05% Food
420
m
390
360
330
300
270
240
210
180
150
120
90
60
30
0
2007 2008 2009 2010 2011 2012 2013 2014 2015
This 53m fund has an investment CONTACT: The AIB Start-Up Accelerator Fund,
policy to invest in companies Michael Culligan/Alex Hobbs managed by ACT Venture Capital,
at the seed and early stages of Dublin BIC was established in 2011 as a 22m
development, across a range of TCD Enterprise Centre Seed Fund. Investments made by
sectors throughout the Republic Pearse Street the fund focus on developing high-
of Ireland. The fund makes seed Dublin 2 growth, export-oriented companies
investments up to approximately in emerging sectors such as
500,000. The fund is now closed TEL: +353 (0)1 4100903 Digital Media, Internet, Software,
for new investees. The fund will E-MAIL: michaelculligan@dublinbic.ie CleanTech and Medical Devices. The
now focus on providing support alexhobbs@dublinbic.ie fund investment range is 100,000
and follow-on investment to its to 650,000.
portfolio companies to assist them WEB: www.dbic.ie
in realising their full potential.
CONTACT:
FUND SIZE: 22 million
Conor OConnor FUND MANAGER:
FUND SIZE: 53 million
Enterprise Equity Venture Capital ACT Venture Capital
FUND MANAGER: The Media Cube
Enterprise Equity Venture Capital Kill Avenue CONTACT:
Group and Dublin Business Dun Laoghaire John Flynn
Innovation Centre Co. Dublin ACT Venture Capital Ltd.
6 Richview Office Park
TEL: +353 (0)1 2145606
CONTACT: Clonskeagh
anna Dibhis E-MAIL: conor@enterpriseequity.ie Dublin 14
AIB Seed Capital Fund
WEB: www.enterpriseequity.ie TEL: +353 (0)1 2600966
NovaUCD
University College Dublin CONTACT:
E-MAIL: info@actvc.ie
Belfield Campus Tom Shinkwin WEB: www.actventure.com
Dublin 4 Enterprise Equity Venture Capital
TEL: +353 (0)1 2866766 The Media Cube
Kill Avenue
E-MAIL: eanna.daibhis@
Dun Laoghaire
aibseedcapitalfund.ie
Co. Dublin
WEB: www.aibseedcapitalfund.ie
TEL: +353 (0)1 2145606
E-MAIL: tom@enterpriseequity.ie
WEB: www.enterpriseequity.ie
This 32m fund incorporates the The Bank of Ireland Start up and
10m Bank of Ireland MedTech Emerging Sectors Equity Fund
Accelerator Fund. Investments are 2010, managed by Delta Partners
made in the range of 100,000 to was established in 2010. This 17m
500,000. The primary focus is on fund has an investment focus on
high potential start-up companies technology-based businesses and
operating in Big Data, ICT, medtech which are headquartered
Energy Efficiency and ICT related in Ireland. The fund has invested in
Healthcare sectors. This fund is companies with disruptive business
open for new investments. models and the potential for fast
growth. The investment range is
100,000 to 650,000. The fund
FUND SIZE: 32 million
is closed for new investments
FUND MANAGER: but continues to make follow-on
Kernel Capital investments in existing portfolio
companies.
CONTACT:
Orla Rimmington, Partner FUND SIZE: 17 million
Rubicon Centre
Rossa Avenue FUND MANAGER:
E-MAIL: seedfund
@deltapartners.com
WEB: www.deltapartners.com
Atlantic Bridge II Limited Bank of Ireland Kernel Delta Equity Fund III
Partnership Capital Partners Private Limited Partnership
Equity Fund II
Atlantic Bridge II Limited This fund has an investment policy Delta Equity Fund III Limited
Partnership is a growth equity fund to invest in Irish companies in Partnership is a 105m venture
focused on technology investments ICT, Environmental Technologies, capital fund managed by Delta
with offices and staff in Dublin, Engineering, Finance and General Partners.
London, Silicon Valley, Beijing and Industry. This fund is now closed
Deltas funds have focused on
Hong Kong. Atlantic Bridge II has for new investments but continues
start-up and early stage technology
been actively investing since July to make follow-on investments in
investments in Communications
2010. The fund is now closed for existing portfolio companies.
Technologies, Software and Life
new investments but continues
Sciences. Delta Partners is often
to make follow on investments in
FUND SIZE: 27 million the first institutional investor in
existing portfolio companies.
a company, typically investing
FUND MANAGER:
500,000 to 5,000,000 and
Kernel Capital taking a minority shareholding.
FUND SIZE: 75 million
This fund is now closed for new
FUND MANAGER: CONTACT: investments but continues to make
Atlantic Bridge II GP Limited Orla Rimmington follow-on investments in existing
Rubicon Centre portfolio companies.
CONTACT: Rossa Avenue
Elaine Coughlan Bishopstown
31 Kildare Street Co. Cork FUND SIZE: 105 million
Dublin 2 FUND MANAGER:
TEL: +353 (0)21 4928974
TEL: +353 (0)1 6034450 Delta Partners
E-MAIL: orla.rimmington@
E-MAIL: info@abven.com kernel-capital.com CONTACT:
E-MAIL: info@deltapartners.com
WEB: www.deltapartners.com
Fountain Healthcare Partners The Frontline Venture Fund Hoxton Ventures Fund 1 (Ireland)
is a 73m Life Science focused I Limited Partnership was Limited Partnership was established
venture capital fund headquartered established in December 2012 in October 2014 as a 5.3m
in Dublin, Ireland with a second primarily investing in early stage fund primarily focussing on Web
office in New York, USA. The fund IT companies. The fund will technologies. The fund will invest
specialises in making investments invest between 250,000 and between 500,000 to 2,000,000
in Biotechnology, Medical Device, 6,000,000 per company over the per company over the life of the
Specialty Pharma and Diagnostic life of the investment. investment. The fund is open for
Companies. Fountain Healthcare new investments.
The fund is open for new
Partners launched its inaugural
investments.
fund (Fountain Healthcare
FUND SIZE: 5.3 million
Partners I) in May 2008. The fund
invests between 500,000 and FUND SIZE: 50 million FUND MANAGER:
7,000,000 per company over Hoxton Ventures Fund 1 (GP) L.P
FUND MANAGER:
the life of the investment. This
fund is closed to new investments Frontline Ventures
CONTACT:
but continues to make follow on Dylan Collins
CONTACT:
investments in existing portfolio Hoxton Ventures Fund 1 (Ireland)
companies. Shay Garvey
Limited Partnership
26-28 Lombard St. East
483 Green Lanes
Dublin 2
FUND SIZE: 73 million London N13 4BS
TEL: +353 (0) 86 2593345 United Kingdom
FUND MANAGER:
Fountain Healthcare Partners E-MAIL: shayg@frontline.vc E-MAIL: businessplans@hoxton.vc
E-MAIL: manus@fh-partners.com
WEB: www.fh-partners.com
The Seroba Life Sciences SOSventures Ireland Fund The Ulster Bank Diageo
Fund II Limited Partnership Limited Partnership Venture Fund Limited
Partnership
Seroba Life Sciences Fund II is SOSventures Ireland Fund Limited Ulster Bank Diageo Venture Fund
a venture capital fund investing Partnership was established in Limited Partnership a 75m fund
in early-stage start-ups to more August 2013 as a 20m fund is managed by Investec Ventures
mature Bioscience and Medical primarily focussing on the Ireland. The fund has invested
Device companies. The fund Technology, Software, Systems at early and expansion stages of
typically invests 1,000,000 to Biology, Synthetic Biology, development across a broad range
7,000,000 over the life of each Indie Biotech bio-coding and of industrial sectors.
investment and is managed from its Telecommunications fields. The
The fund investment range is
offices in Dublin. The fund is closed SOSventures Ireland Fund will run a
1,000,000 to 5,000,000.
to new investments but continues number of accelerator programs in
The fund is now closed for new
to make follow on investments in Ireland to assist in finding suitable
investments but continues to make
existing portfolio companies. SMEs.
follow on investments in existing
The fund will invest between portfolio companies.
FUND SIZE: 75 million 50,000 to 2,000,000 per
company over the life of the
FUND MANAGER: FUND SIZE: 75 million
investment. The fund is open for
Seroba Life Sciences Limited new investments. FUND MANAGER:
Investec Ventures Ireland
CONTACT:
Peter Sandys FUND SIZE: 20 million
CONTACT:
6 Northbrook Road FUND MANAGER: Michael Murphy / Leo Hamill /
Ranelagh, Dublin 6 SOSV Limited Derek Crawley
Ireland
The Harcourt Building
TEL: +353 (0)1 6334028 CONTACT: Harcourt Street
Bill Liao Dublin 2
E-MAIL: petersandys
SOSV Limited Ireland
@seroba-lifesciences.com 2nd Floor, Penrose Wharf
TEL: +353 (0)1 4210000
WEB: www.seroba-lifesciences.com Alfred Street
Cork E-MAIL: michael.murphy@investec.ie
leo.hamill@investec.ie
TEL: +353 (0)21 4700991
derek.crawley@investec.ie
E-MAIL: bill.liao@sosv.com
WEB: www.investec.ie
WEB: www.sosv.com
Name of Company
Nature of Business
Name of Company
Nature of Business
Name of Company
Nature of Business
Name of Company
Nature of Business
Name of Company
Nature of Business
* Fund closed
** 67.5 million of the Atlantic Bridge Ventures Limited Partnership relates to the Seed and Venture Capital Programme 2007-2012.
NUMBER OF
INVESTMENTS
Breakdown of
Investments
Cumulative to
December 2015 302 Start Up
(% by number)
386 Early Stage
91 Development
AMOUNT OF
INVESTMENT
Breakdown of
Investments
Cumulative to 24.79% Start Up
December 2015
49.97% Early Stage
(% by value)
25.24% Development
REGIONAL
BREAKDOWN OF
INVESTMENTS 0.47% Border
Cumulative to
December 2015 50.23% Dublin & County
(% by value)
1.62% South East
7.27% West
20.86% Other
1.97% Midlands
SECTORAL
BREAKDOWN OF 182 Communications
INVESTMENTS
Cumulative to 4 Food
December 2015
4 Manufacturing
(by number)
28 Miscellaneous
328 Software
SECTORAL
BREAKDOWN OF 30.15% Communications
INVESTMENTS
0.22% Food
Cumulative to
December 2015 0.45% Manufacturing
(% by value)
3.24% Miscellaneous
47.41% Software
360
m
330
300
270
240
210
180
150
120
90
60
30
0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Atlantic Bridge Limited Partnership This 27 million fund has an Delta Partners, an early stage
is a growth equity fund focused investment policy to invest in technology venture capital firm,
on technology investments with Irish companies in ICT, Telecoms, based in Dublin invested its third
offices and staff in Dublin, London, Healthcare, Life Sciences and fund, the 90m Delta Equity
Silicon Valley Beijing and Hong General Industry. Investments Fund II Limited Partnership. The
Kong. Atlantic Bridge I has been are in the range of 250,000 to fund is closed to new investments
actively investing since 2005. The 3,000,000. This fund is now fully and continues to make follow-on
fund is closed to new investments invested. investments in existing portfolio
but continues to make follow on companies.
investments in existing portfolio
FUND SIZE: 27 million To date, the majority of investments
companies.
from Deltas funds have focused on
FUND MANAGER:
start-up and early stage technology
Kernel Capital investments in Communications
FUND SIZE: 98.5 million
Technologies, Software and Life
FUND MANAGER: CONTACT: Sciences.
Atlantic Bridge GP Limited Orla Rimmington, Partner
Rubicon Centre
CONTACT: Rossa Avenue FUND SIZE: 90 million
Elaine Coughlan Bishopstown FUND MANAGER:
31 Kildare Street Co. Cork Delta Partners
Dublin 2
TEL: +353 (0)21 4928974
TEL: +353 (0)1 6034450 CONTACT:
E-MAIL: orla.rimmington Dermot Berkery / Maurice Roche
E-MAIL: info@abven.com @kernel-capital.com Media House
WEB: www.abven.com WEB: www.kernel-capital.com South County Business Park
Leopardstown
Dublin 18
E-MAIL: info@deltapartners.com
WEB: www.deltapartners.com
The European BioScience Fund I, Enterprise Equity Venture Capital The EVP Early Stage Technology
managed by North Wall General Group manages Enterprise Equity Fund was established in 2002.
Partners Ltd. was established in Investment Fund (15m) and The fund invests in early stage
2002. The European BioScience Enterprise Equity Seed Capital High Potential Start-up (HPSU)
Fund I invests in seed and Fund (7m). These two funds are companies in the Information,
early stage opportunities in the now closed for investment in new Communications and Technology
Bioscience sector. investees. (ICT) Sector.
This fund is now closed for new This fund is now closed for new
investments. FUND SIZE: 22 million investments.
FUND MANAGER:
FUND SIZE: 12.7 million Enterprise Equity Venture Capital FUND SIZE: 10 million
Group
FUND MANAGER: FUND MANAGER:
North Wall General Partners Ltd EVP Management Ltd
CONTACT:
Conor OConnor / Tom Shinkwin
CONTACT: CONTACT:
The Media Cube
Michael Donnelly Gerry Jones
Kill Avenue
The Warehouse Executive Venture Partners
Dun Laoghaire
6 & 7 Barrow St The Arches
Co. Dublin
Dublin 4 Carpenterstown Road
TEL: +353 (0)1 2145606 Castleknock
TEL: +353 (0)1 8088880
Dublin 15
E-MAIL: conor@enterpriseequity.ie
E-MAIL: grow@growcorp.net Ireland
tom@enterpriseequity.ie
TEL: +353 (0)1 6639206
WEB: www.enterpriseequity.ie
MOBILE: +353 (0)86 2429993
E-MAIL: gerry.jones@evp.ie
WEB: www.evp.ie
The 20 million Irish BioScience The Guinness Ireland Ulster Bank 4th Level Ventures University
Venture Capital Fund is a specialist Equity Fund Limited Partnership is Seed Fund was established in
Life Science fund managed by a 19 million fund set up in 2001. 2002. Investees are high potential
Seroba BioVentures. The fund It is a follow on to the Guinness businesses in the seed or early
focuses on early-stage Life Science Ulster Bank Equity Fund Limited stage of their development arising
companies on the island of Ireland Partnership fund set up in 1997. This out of research in Irish third level
with investments typically in the fund is now fully invested. institutions.
200,000 to 2,000,000 range.
The fund investments are in the
The fund is now fully invested.
FUND SIZE: 19 million Life Sciences, Material Sciences,
Technology and information,
FUND MANAGER:
FUND SIZE: 20 million Communications and Technology
Investec Ventures Ireland (ICT) sectors. The fund is closed for
FUND MANAGER:
new investments.
Seroba BioVentures CONTACT:
Michael Murphy / Leo Hamill /
CONTACT: Derek Crawley FUND SIZE: 17.18 million
Peter Sandys The Harcourt Building FUND MANAGER:
6 Northbrook Road, Ranelagh Harcourt Street 4th Level Ventures Ltd
Dublin 6 Dublin 2
Ireland CONTACT:
TEL: +353 (0)1 6334028
TEL: +353 (0)1 4210000 Alan Wall
E-MAIL: petersandys
75 St. Stephens Green
@seroba-lifesciences.com E-MAIL: Michael.murphy@investec.ie Dublin 2
leo.hamill@investec.ie
WEB: www.seroba-lifesciences.com
derek.crawley@investec.ie TEL: +353 (0)1 6333627
Name of Company
Nature of Business
Name of Company
Nature of Business
Name of Company
Nature of Business
The EU Seed and Venture Capital Measure, under the Operational Programme for Industrial
Development 1994 - 1999, which was co-financed by the European Regional Development Fund
(ERDF), was set up with the objective of establishing Venture Capital Funds to provide early
stage, small and medium-sized growth oriented enterprises in Ireland with equity capital. Fifteen
venture capital funds were established under this Programme.
Under the Programme, 129 million was invested in 146 companies. Investment in regionally
located projects outside Dublin totalled 38 million (29%). Investment in software related projects
totalled 92 million (71%).
A detailed list of the performance of the various funds established under this Programme is set
out on the following page.
Enterprise Ireland has overall responsibility for the management and reporting of the Programme.
All investment decisions are made by private sector Venture Capital Fund Managers. These funds
are now closed for new investment but continue to be managed to achieve exits.
The Guinness Ulster Bank Equity Fund Limited Partnership * 7,618 29 6,602
* Fund closed
Niall ODonnellan
Divisional Manager
Policy, People & Investment
Enterprise Ireland
Donnchadh Cullinan
Department Manager
Banking Relationships and Growth Capital Department
Enterprise Ireland
Don Harrington
Director Corporate Finance
Goodbody Stockbrokers
Tony Haslam
Consultant
Praig Hennessy
Department of Jobs, Enterprise & Innovation
Eileen McGoldrick
Secretary to the Committee